Global Leading Market Research Publisher QYResearch announces the release of its latest report "Hemofiltration Tubing Set - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Hemofiltration Tubing Set market, including market size, share, demand, industry development status, and forecasts for the next few years.

For nephrologists, dialysis center managers, and intensive care unit (ICU) staff, performing hemofiltration therapy requires disposable tubing assemblies that connect the patient's blood circulation to the hemofiltration device, enabling blood filtration and fluid replacement. The global Hemofiltration Tubing Set market addresses this need through arterial and venous blood lines, replacement fluid lines, and necessary connectors, ensuring a safe, effective, and sterile treatment process for patients with acute kidney injury or end-stage renal disease.

The global market for Hemofiltration Tubing Set was estimated to be worth US$ 528 million in 2025 and is projected to reach US$ 744 million, growing at a CAGR of 5.1% from 2026 to 2032. In 2024, global sales volume reached 116 million units, with an average price of USD 4.3 per unit. This steady growth reflects increasing dialysis patient populations and ICU utilization.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097065/hemofiltration-tubing-set

Disposable Tubing for Hemofiltration Therapy
The Hemofiltration Tubing Set is a disposable tubing assembly used in hemofiltration therapy, connecting the patient's blood circulation to the hemofiltration device to enable blood filtration and fluid replacement. The set typically includes arterial and venous blood lines, replacement fluid lines, and necessary connectors, ensuring a safe, effective, and sterile treatment process.

Key components include arterial blood line (blood withdrawal from patient), venous blood line (blood return to patient), replacement fluid line (infusion of substitution fluid), pressure monitoring lines, and anticoagulant infusion line. Sets are sterilized (ethylene oxide or gamma irradiation) for single-use. Adult and pediatric sizes accommodate different blood volumes and flow rates.

Industry Segmentation: Patient Size & Care Settings
The Hemofiltration Tubing Set market is segmented by patient population and healthcare facility:

Adult Tubing Set: Standard size for adult patients (blood flow 150-400 mL/min). A dialysis center reported that adult tubing sets are used for 90% of chronic hemodialysis patients.

Pediatric Tubing Set: Smaller priming volume and blood flow (30-150 mL/min) for children and neonates.

Application Segments
Hospital: ICU and acute care for continuous renal replacement therapy (CRRT) and slow low-efficiency dialysis (SLED). A hospital ICU reported using 50+ tubing sets monthly for CRRT.

Clinic: Outpatient hemodialysis clinics.

Dialysis Center: Freestanding chronic dialysis facilities.

Technology Developments & Market Trends
Over the past six months, several advancements have shaped the market. Pre-connected, closed-system tubing sets reduce infection risk and setup time. Integrated pressure sensors for real-time monitoring. Air elimination filters to prevent air embolism. Needle-free connectors for reduced needlestick injuries.

The trend toward CRRT in ICU for acute kidney injury (AKI) drives demand for specialty tubing sets. Home hemodialysis expansion requires user-friendly, pre-connected sets. Infection control priorities (bloodstream infections) favor closed-system designs.

Regional Market Dynamics
Asia-Pacific dominates the hemofiltration tubing set market, driven by large dialysis patient populations in China, India, and Southeast Asia, and cost-sensitive procurement. China leads in production and consumption.

North America follows, with high CRRT utilization in ICUs and home hemodialysis adoption. Europe has steady demand from established dialysis networks.

Competitive Landscape
Key players include Fresenius Medical Care, B. Braun Avitum AG, Naniwa Rubber Industry, Sb-Kawasumi Laboratories, JMS, Infomed SA, Perfect Medical, Vital Healthcare Sdn. Bhd., Bain Medical, Guangdong Baihe Medical, Tianjin Hanaco Medical, Henan Shuguang Jianshi Industrial Development, Weihai Weigao Blood Purification Products, Henan Tuoren Health Technology, Anhui Tiankang Medical Technology, Jiangxi Hongda Medical Equipment Group, Ningbo Tianyi Medical Appliance, Chengdu Xinjin ShiFeng Medical Apparatus & Instrument, and Well Lead Medical.

Market Segmentation
The Hemofiltration Tubing Set market is segmented as below:

By Company

Fresenius Medical Care

B.Braun Avitum AG

Naniwa Rubber Industry

Sb-Kawasumi Laboratories

JMS

Infomed SA

Perfect Medical

Vital Healthcare Sdn. Bhd.

Bain Medical

Guangdong Baihe Medical

Tianjin Hanaco Medical

Henan Shuguang Jianshi Industrial Development

Weihai Weigao Blood Purification Products

Henan Tuoren Health Technology

Anhui Tiankang Medical Technology

Jiangxi Hongda Medical Equipment Group

Ningbo Tianyi Medical Appliance

Chengdu Xinjin ShiFeng Medical Apparatus&Instrument

Well Lead Medical

Segment by Type

Adult Tubing Set

Pediatric Tubing Set

Segment by Application

Hospital

Clinic

Dialysis Center

Exclusive Industry Outlook
Looking ahead, the convergence of hemofiltration tubing set technology with closed-system design, integrated sensors, and home dialysis represents a steady growth opportunity. Development of tubing sets with integrated blood leak detectors. Color-coded lines for error prevention. Additionally, the expansion of home hemodialysis and acute kidney injury treatment will drive demand for user-friendly, reliable tubing sets. The ability to offer hemofiltration tubing sets that combine safety, sterility, and ease of use—supported by regulatory compliance and supply chain reliability—will define competitive differentiation.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp